BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra, who will soon depart the agency, highlighted the record number of people who have signed up for health insurance since he took the helm of the sprawling agency — and President Joe Biden’s role in it, Chelsea reports.
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and stronger."
Sen. Ted Cruz supports Pam Bondi's confirmation as attorney general, calling her Trump's most crucial nominee and praising her strong hearing performance.
U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for the 15 drugs targeted for Medicare price negotiations for 2027 because they are too expensive.
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Secretary Xavier Becerra spoke to The Washington Post about falling trust in his department since the coronavirus pandemic.
U.S. Health and Human Services Secretary Xavier Becerra has indicated the government's intention to negotiate more affordable prices for 15 expensive Medicare drugs by 2027. Becerra emphasizes the effectiveness of the medications but insists their costs need reduction,